Key Takeaways TransMedics, KORU Medical Systems and Cardinal Health delivered one-year returns well ahead of the S&P 500.TMDX surged on Organ Care System adoption, NOP expansion, improving service revenue and operating leverage.CAH gained as pharma and specialty demand lifted earnings, cash flow and prompted higher fiscal 2026 outlook.Beating the S&P 500 over a sustained period requires more than headline-driven rallies or short-term multiple expansion. In MedTech, durable outperformance is typically underp ...